Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Mater Chem B ; 12(17): 4097-4117, 2024 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-38587869

RESUMEN

Single phototherapy and immunotherapy have individually made great achievements in tumor treatment. However, monotherapy has difficulty in balancing accuracy and efficiency. Combining phototherapy with immunotherapy can realize the growth inhibition of distal metastatic tumors and enable the remote monitoring of tumor treatment. The development of nanomaterials with photo-responsiveness and anti-tumor immunity activation ability is crucial for achieving photo-immunotherapy. As immune adjuvants, photosensitizers and photothermal agents, manganese-based nanoparticles (Mn-based NPs) have become a research hotspot owing to their multiple ways of anti-tumor immunity regulation, photothermal conversion and multimodal imaging. However, systematic studies on the synergistic photo-immunotherapy applications of Mn-based NPs are still limited; especially, the green synthesis and mechanism of Mn-based NPs applied in immunotherapy are rarely comprehensively discussed. In this review, the synthesis strategies and function of Mn-based NPs in immunotherapy are first introduced. Next, the different mechanisms and leading applications of Mn-based NPs in immunotherapy are reviewed. In addition, the advantages of Mn-based NPs in synergistic photo-immunotherapy are highlighted. Finally, the challenges and research focus of Mn-based NPs in combination therapy are discussed, which might provide guidance for future personalized cancer therapy.


Asunto(s)
Inmunoterapia , Manganeso , Humanos , Manganeso/química , Manganeso/farmacología , Inmunoterapia/métodos , Fototerapia/métodos , Tecnología Química Verde , Neoplasias/terapia , Neoplasias/tratamiento farmacológico , Animales , Nanoestructuras/química , Fármacos Fotosensibilizantes/química , Fármacos Fotosensibilizantes/farmacología , Fármacos Fotosensibilizantes/síntesis química , Antineoplásicos/química , Antineoplásicos/farmacología , Antineoplásicos/síntesis química , Tamaño de la Partícula
2.
ChemSusChem ; 15(20): e202200822, 2022 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-36005744

RESUMEN

The development of catalysts with relatively high current densities at low potentials for the electrooxidation of 5-hydroxymethylfurfural (HMF) is still challenging. In this study, an in situ deep eutectic solvent (DES) etching phosphorization strategy is developed to prepare nickel phosphides encapsulated in P,O-codoped carbon nanosheets (Ni-P@POC). The DES serves not only as an etchant to extract Ni2+ from the nickel foam, but also as a phosphorus source to form nickel phosphides in situ uniformly embedded in the carbon films to produce a sheet structure. The electrooxidation performance is further greatly improved by implementing an electrochemical activation step to transform Ni-P@POC into NiOOH/Ni-P@POC (t-Ni-P@POC). t-Ni-P@POC exhibits a low onset potential of 1.20 V vs. RHE and a high current density of 200 mA cm-2 at 1.33 V vs. RHE for HMF electrooxidation, outperforming most reported catalysts. The as-developed DES etching phosphorization strategy offers a facile, flexible, and universal route for the design of high-performance catalysts with specific nanostructures.


Asunto(s)
Disolventes Eutécticos Profundos , Níquel , Níquel/química , Fósforo/química , Carbono
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA